Release of mucus glycoconjugates by Pseudomonas aeruginosa rhamnolipid into feline trachea in vivo and human bronchus in vitro.
Pseudomonas aeruginosa colonizes the lower respiratory tracts of patients with severe bronchiectasis, including cystic fibrosis, a condition associated with increased airway mucus output. We have shown that an extract containing chloroform-soluble extracellular products of P. aeruginosa releases glycoconjugates into the cat trachea in vivo. This activity was not related to pyocyanin, a major component of the extract, but was associated with the rhamnolipids. Purified monorhamnolipid (100 micrograms/ml) released radiolabeled and periodic acid-Schiff (PAS)-reactive glycoconjugates (delta 3H = +490 +/- 70%, delta 35S = +170 +/- 40%, delta PAS = +8.6 +/- 1.7 micrograms/min; n = 6, P less than 0.02 for each). Dirhamnolipid (200 micrograms/ml) was also effective (delta 3H = +640 +/- 70%, delta 35S = +130 +/- 20%, delta PAS = +9.3 +/- 1.5 micrograms/min; n = 6, P less than 0.02 for each). Monorhamnolipid (100 micrograms/ml) also released 35S-labeled and PAS-reactive glycoconjugates from human bronchial tissue in vitro (delta 35S = +189 +/- 47%, delta PAS = +26.3 +/- 8.5 micrograms/min; n = 7, P less than 0.001 versus control tissues in which no stimulus was given). The cat tracheal glycoconjugates released by the rhamnolipids differed from those released by pilocarpine 50 microM, in having a higher 3H:35S ratio (P less than 0.001). After gel chromatography on a Sepharose CL-4B column, the void volume fractions of the glycoconjugates also had different profiles in a cesium chloride density gradient. Those released by rhamnolipid banded at 1.62 g/ml, while those released by pilocarpine banded mainly at 1.50 g/ml, with some of the higher density material also present.(ABSTRACT TRUNCATED AT 250 WORDS)
Somerville
M
M
Department of Physiology, St. George's Hospital Medical School, London, United Kingdom.
Taylor
G W
GW
Watson
D
D
Rendell
N B
NB
Rutman
A
A
Todd
H
H
Davies
J R
JR
Wilson
R
R
Cole
P
P
Richardson
P S
PS
D000818:Animals; D001980:Bronchi / Q000378:metabolism*; D002415:Cats; D006017:Glycolipids / Q000737:chemistry / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D009093:Mucus / Q000187:drug effects / Q000378:metabolism* / Q000382:microbiology; D010619:Phenazines / Q000494:pharmacology; D010860:Pigments, Biological / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000502:physiology*; D014132:Trachea / Q000187:drug effects / Q000378:metabolism* / Q000382:microbiology
D006017:Glycolipids; D010619:Phenazines; D010860:Pigments, Biological